Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: Modification by genes, diet and behavior

Neurobiology of Aging

Volumn 23, Issue 5, 2002, Pages 695-705

  Mattson, Mark P ^a,b   Duan, Wenzhen ^a   Chan, Sic L ^a   Cheng, Aiwu ^a   Haughey, Norman ^a   Gary, Devin S ^a   Guo, Zhihong ^a   Lee, Jaewon ^a   Furukawa, Katsutoshi ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein; Apoptosis; BDNF; Caloric restriction; Chaperone; Folic acid; Parkinson's disease; Telomerase

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; ANDROGEN RECEPTOR; ANTIOXIDANT; CHAPERONE; CYTOKINE; FOLIC ACID; HEAT SHOCK PROTEIN; HUNTINGTIN; INHIBITOR OF APOPTOSIS PROTEIN; NEUROTROPHIC FACTOR; PARKIN; PRESENILIN 1; PROTEIN BCL 2; TELOMERASE;

AGING; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CALORIC RESTRICTION; CELL MOTILITY; CELL SURVIVAL; COGNITION; DIET; DISEASE RESISTANCE; DNA REPAIR; GENOME; GLIA; HORMESIS; HUMAN; HUNTINGTON CHOREA; MUTATION; NERVE CELL; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; STROKE; TRINUCLEOTIDE REPEAT; VITAMIN SUPPLEMENTATION;

AGED; AGING; BRAIN; BRAIN DISEASES; CALORIC RESTRICTION; DIET; HEALTH BEHAVIOR; HUMANS; SIGNAL TRANSDUCTION;

EID: 0036752830     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00025-8     Document Type: Article

References (126)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E.et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 25:2000;239-252.
2. Albensi B.C., Sullivan P.G., Thompson M.B., Scheff S.W., Mattson M.P. Cyclosporin ameliorates traumatic brain injury-induced alterations of hippocampal synaptic plasticity. Exp. Neurol. 162:2000;385-389.
3. Altar C.A. Neurotrophins and depression. Trends Pharmacol. Sci. 20:1999;59-61.
4. Bertoni-Freddari C., Fattoretti P., Paoloni R., Caselli U., Galeazzi L., Meier-Ruge W. Synaptic structural dynamics and aging. Gerontology. 42:1996;170-180.
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:2000;1301-1306.
6. Bjorklund A. Cell replacement strategies for neurodegenerative disorders. Novartis Found Symp. 231:2000;7-15.
7. q/11. J. Neurochem. 69:1997;570-580.
8. Bruce-Keller A.J., Umberger G., McFall R., Mattson M.P. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45:1999;8-15.
9. Bui N.T., Livolsi A., Peyron J.F., Prehn J.H. Activation of nuclear factor kappa B and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of I kappa B alpha. J. Cell Biol. 152:2001;753-764.
10. Butterfield D.A., Howard B.J., Yatin S., Allen K.L., Carney J.M. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 94:1997;674-678.
11. Caidwell M.A., He X., Wilkie N., Pollack S., Marshall G., Wafford K.A.et al. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat. Biotechnol. 19:2001;475-479.
12. Cakatay U., Telci A., Kayali R., Tekeli F., Akcay T., Sivas A. Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain. Exp. Gerontol. 36:2001;221-229.
13. Checkoway H., Farin F.M., Costa-Mallen P., Kirchner S.C., Costa L.G. Genetic polymorphisms in Parkinson's disease. Neurotoxicology. 19:1998;635-643.
14. Citron M. Secretases as targets for the treatment of Alzheimer's disease. Mol. Med. Today. 6:2000;392-397.
15. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, Vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55:1998;1449-1455.
16. Culmsee C., Zhu Z., Yu Q.S., Chan S.L., Camandola S., Guo Z.et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β-peptide. J. Neurochem. 77:2001;220-228.
17. Dobkin B.H. Activity-dependent learning contributes to motor recovery. Ann. Neurol. 44:1998;158-160.
18. Duan W., Mattson N.W. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57:1999;195-206.
19. Duan W., Guo Z., Mattson M.P. Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J. Neurochem. 76:2001;619-626.
20. Duan W, Ladenheim B, Cutler RG, Cadet JL, Mattson MP. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. Ann Neurol, in press.
21. Dubey A., Forster M.J., Lal H., Sohal R.S. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch. Biochem. Biophys. 333:1996;189-197.
22. Elkind M.S., Sacco R.L. Stroke risk factors and stroke prevention. Semin. Neurol. 18:1998;429-440.
23. Estus S., Tucker H.M., van Rooyen C., Wright S., Brigham E.F., Wogulis M.et al. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction. J. Neurosci. 17:1997;7736-7745.
24. Evans D.A., Hebert L.E., Beckett L.A., Scherr P.A., Albert M.S., Chown M.J.et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch. Neurol. 54:1997;1399-1405.
25. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P.et al. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5856-5861.
26. Finch CE, Morgan TE. Food restriction and brain aging. In: Mattson MP, Geddes JW, editors. The aging brain. Adv Cell Aging Gerontol 1997;2:279-97.
27. Frydman J. Folding of newly translated proteins in vivo: the role of molecular chaperones. Ann. Rev. Biochem. 70:2001;603-647.
28. Fu W., Killen M., Culmsee C., Dhar S., Pandita T.K., Mattson M.P. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 14:2000;3-15.
29. Furukawa K., Barger S.W., Blalock E.M., Mattson M.P. Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid precursor protein. Nature. 379:1996;74-78.
30. Gage F.H. Mammalian neural stem cells. Science. 287:2000;1433-1438.
31. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C.et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
32. Gary D.S., Mattson M.P. Integrin signaling via the P13-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J. Neurochem. 76:2001;1485-1496.
33. Gash D.M., Zhang Z., Gerhardt G. Neuroprotective and neurorestorative properties of GDNF. Ann. Neurol. 44:1998;S121-S125.
34. Gething M.J. Role and regulation of the ER chaperone BiP. Semin. Cell Dev. Biol. 10:1999;465-472.
35. Guo Z.H., Mattson M.P. Neurotrophic factors protect synaptic terminals against arnyloid- and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function. Cerebral Cortex. 10:1999;50-57.
36. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M.et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5:1999;101-106.
37. Guo Z., Ersoz A., Butterfield D.A., Mattson M.P. Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose transport and mitochondrial function after exposure to amyloid β-peptide and oxidative and metabolic insults. J. Neurochem. 75:2000;314-320.
38. Guo Z., Lee J., Lane M.A., Mattson M.P. Iodoacetate protects hippocampal neurons against excitotoxic and oxidative injury: involvement of heat-shock proteins and Bcl-2. J. Neurochem. 79:2001;361-370.
39. Gutzmann H., Hadler D. Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study. J. Neural. Trans. Suppl. 54:1998;301-310.
40. Haughey N.J., Liu D., Nath A., Borchard A.C., Mattson M.P. Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. NeuroMolecular Med. 1:2002;125-136.
41. Hess D.T., Matsumoto A., Nudelman R., Stamler J.S. S-nitrosylation: spectrum and specificity. Nat. Cell Biol. 3:2001;E46-E49.
42. Hoyer S. Age-related changes in cerebral oxidative metabolism. Implications for drug therapy. Drugs Aging. 6:1995;210-218.
43. Ickes B.R., Pham T.M., Sanders L.A., Albeck D.S., Mohammed A.H., Granholm A.C. Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp. Neurol. 164:2000;45-52.
44. Ingram D.K., Weindruch R., Spangler E.L., Freeman J.R., Walford R.L. Dietary restriction benefits learning and motor performance of aged mice. J. Gerontol. 42:1987;78-81.
45. Ingram D.K. Vaccine development for Alzheimer's disease: a shot of good news. Trends Neurosci. 24:2001;305-307.
46. Ishida A., Furukawa K., Keller J.N., Mattson M.P. Secreted form of beta-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport. 8:1997;2133-2137.
47. Jankowsky J.L., Pauerson P.H. Cytokine and growth factor involvement in long-term potentiation. Mol. Cell Neurosci. 14:1999;273-286.
48. Jenner P., Olanow C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44:1998;S72-S84.
49. Jick H., Zornberg G.L., Jick S.S., Seshadri S., Drachman D.A. Statins and the risk of dementia. Lancet. 356:2000;27-1631.
50. Jin L.W., Saitoh T. Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy. Drugs Aging. 6:1995;136-149.
51. Kalimo H., Viitanen M., Amberla K., Juvonen V., Marttila R., Poyhonen M.et al. CADASIL: hereditary disease of arteries causing brain infarcts and dementia. Neuropathol. Appl. Neurobiol. 25:1999;257-265.
52. Keller T.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G.et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997;273-284.
53. Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M.et al. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6753-6758.
54. Kempermann G., Kuhn H.G., Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature. 386:1997;493-495.
55. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S.et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608.
56. Klapper W., Shin T., Mattson M.P. Differential regulation of telomerase activity and TERT expression during brain development in mice. J. Neurosci. Res. 64:2001;252-260.
57. Kruman I., Chan S.L., Culmsee C., Kruman Y., Penix L., Mattson M.P. Homocysteine elicits a DNA damage response in neurons resulting in apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20:2000;6920-6926.
58. Kruman I.I., Kumaravel T.S., Lohani A., Cutler R.G., Pedersen W.A., Kruman Y., Evans M., Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair and sensitize hippocampal neurons to death in experimental models of Alzheimer's disease. J. Neurosci. 22:2002;1752-1762.
59. Kuhn H.G., Dickinson-Anson H., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16:1996;2027-2033.
60. Kuhn W., Roebroek R., Blom H., van Oppenraaij D., Przuntek H., Kretschmer A.et al. Elevated plasma levels of homocysteine in Parkinson's disease. Eur. Neurol. 40:1998;225-227.
61. Kumar V.B., Franko M.W., Farr S.A., Armbrecht H.J., Morley J.E. Identification of age-dependent changes in expression of senescence-accelerated mouse (SAMP8) hippocampal proteins by expression array analysis. Biochem. Biophys. Res. Commun. 272:2000;657-661.
62. LeBel C.P., Bondy S.C. Oxidative damage and cerebral aging. Prog. Neurobiol. 38:1992;601-609.
63. Lee J., Duan W., Long J.M., Ingram D.K., Mattson M.P. Dietary restriction increases survival of newly-generated neural cells and induces BDNF expression in the dentate gyrus of rats. J. Mol. Neurosci. 15:2000;99-108.
64. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25:2000;294-297.
65. Liu J., Solway K., Messing R.O., Sharp F.R. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18:1998;7768-7778.
66. Logroscino G., Marder K., Cote L., Tang M.X., Shea S., Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann. Neurol. 39:1996;89-94.
67. Long J.M., Mouton P.R., Jucker M., Ingram D.K. What counts in brain aging? Design-based stereological analysis of cell number. J. Gerontol. A Biol. Sci. Med. Sci. 54:1999;B407-B417.
68. Lowenstein D.H., Chan P.H., Miles M.F. The stress protein response in cultured neurons: characterization and evidence for a protective role in excitotoxicity. Neuron. 7:1991;1053-1060.
69. Lu C., Fu W., Mattson M.P. Telomerase protects developing neurons against DNA damage-induced cell death. Dev. Brain Res. 131:2001;167-171.
70. Ludoiph A.C. Treatment of amyotrophic lateral sclerosis - what is the next step? J. Neurol. 246:2000;S13-S18.
71. Lye T.C., Shores E.A. Traumatic brain injury as a risk factor for Alzheimer's disease: a review. Neuropsychol. Rev. 10:2000;115-129.
72. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20:2000;9104-9110.
73. 2+ homeostasis and cell death. J. Neurosci. 15:1995;6239-6249.
74. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 68:1997;255-264.
75. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17:1997;1046-1054.
76. Markesbery WR, Montine TJ, Lovell MA. Oxidative alterations in neurodegenerative diseases. In: Mattson MP, editor. Pathogenesis of neurodegenerative disorders. Totowa, NJ: Human Press Inc., 2001. p. 21-51.
77. Mattson M.P. Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27:1992;29-49.
78. i and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65:1995;1740-1751.
79. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1997;1081-1132.
80. Mattson M.P. Neuroprotective signal transduction: relevance to stroke. Neurosci. Biobehav. Rev. 21:1997;193-206.
81. Mattson MP, Lindvall O. Neurotrophic factor and cytokine signaling in the aging brain. In: Mattson MP, Geddes JW, editors. The aging brain (Greenwich CT: JAI Press), Adv Cell Aging Gerontol 1997;2:299-345.
82. Mattson M.P., Goodman Y., Luo U., Fu W., Furukawa K. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49:1997;681-697.
83. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21:1998;53-57.
84. Mattson M.P., Guo Z.H., Geiger J.D. Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J. Neurochem. 73:1999;532-537.
85. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1:2000;120-129.
86. Mattson M.P. Creatine: prescription for bad genes and a hostile environment? Trends Neurosci. 23:2000;511.
87. Mattson M.P., Camandola S. NF-κB in neurodegenerative disorders. J. Clin. Invest. 107:2001;247-254.
88. Mattson MP, Pandita TE, editors. Telomerase, aging and disease. Amsterdam: Elsevier, 2001.
89. Mattson M.P., Fu W., Zhang P. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech. Ageing Dev. 122:2001;659-671.
90. Mattson M.P., Duan W., Lee J., Guo Z. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech. Ageing Dev. 122:2001;757-778.
91. Mayeux R., Costa R., Bell K., Merchant C., Tung M.X., Jacobs D. Reduced risk of Alzheimer's disease among individuals with low calorie intake. Neurology. 59:1999;S296-S297.
92. Mehler M.F., Mabie P.C., Zhu G., Gokhan S., Kessler J.A. Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev. Neurosci. 22:2000;74-85.
93. McDonald J.W., Liu X.Z., Qu Y., Liu S., Mickey S.K., Turetsky D.et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5:1999;1410-1412.
94. Mezey E., Chandross K.J. Bone marrow: a possible alternative source of cells in the adult nervous system. Eur. J. Pharmacol. 405:2000;297-302.
95. Miller F.D., Pozniak C.D., Walsh G.S. Neuronal life and death: an essential role for the p53 family. Cell Death Differ. 7:2000;880-888.
96. Munch G., Thome J., Foley P., Schinzel R., Riederer P. Advanced glycation end products in ageing and Alzheimer's disease. Brain Res. Rev. 23:1997;134-143.
97. Nilsson M., Perfilieva E., Johansson U., Orwar O., Eriksson P. Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory. J. Neurobiol. 39:1999;569-578.
98. Papaioannou N., Tooten P.C., van Ederen A.M., Bohl J.R., Rofina J., Tsangaris T.et al. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid. 8:2001;11-21.
99. Pedersen W.A., Chan S.L., Mattson M.P. A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 74:2000;1426-1433.
100. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A.et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
101. Rao M.S., Mattson M.P. Stem cells and aging: expanding the possibilities. Mech. Ageing Dev. 122:2001;713-734.
102. Richard F., Amouyel P. Genetic susceptibility factors for Alzheimer's disease. Eur. J. Pharmacol. 412:2001;1-12.
103. Roman G.C. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J. Neurol. Neurosurg. Psychiatry. 61:1996;131-137.
104. Roth G.S., Joseph J.A. Cellular and molecular mechanisms of impaired dopaminergic function during aging. Ann. NY Acad. Sci. 719:1994;129-135.
105. Saito S., Kobayashi S., Ohashi Y., Igarashi M., Komiya Y., Ando S. Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents. J. Neurosci. Res. 39:1994;57-62.
106. Samii A., Markopoulou K., Wszolek Z.K., Sossi V., Dobko T., Mak E.et al. PET studies of Parkinsonism associated with mutation in the alpha-synuclein gene. Neurology. 53:1999;2097-2102.
107. Schwab M.E. Regenerative nerve fiber growth in the adult central nervous system. News Physiol. Sci. 13:1998;294-298.
108. Shadlen M.F., Larson E.B. What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options. Postgrad. Med. 105:1999;109-118.
109. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature. 410:2001;372-376.
110. Sloane J.A., Hollander W., Moss M.B., Rosene D.L., Abraham C.R. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol. Aging. 20:1999;395-405.
111. Sohal R.S., Agarwal S., Candas M., Forster M.J., Lal H. Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech. Ageing Dev. 76:1994;215-224.
112. Sousa N., Lukoyanov N.V., Madeira M.D., Almeida O.F., Paula-Barbosa M.M. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience. 97:2000;253-266.
113. Sun Y., Nadal-Vicens M., Misono S., Lin M.Z., Zubiaga A., Hua X.et al. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell. 104:2001;365-376.
114. Tan E.K., Khajavi M., Thomby J.I., Nagarnitsu S., Jankovic J., Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology. 55:2000;533-538.
115. Tanigaki K., Nogaki F., Takahashi J., Tashiro K., Kurooka H., Honjo T. Notch-1 and Notch-3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate. Neuron. 29:2001;45-55.
116. Tobin A.J., Signer E.R. Huntington's disease: the challenge for cell biologists. Trends Cell Biol. 10:2000;531-536.
117. van Praag H., Kemperrnann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 2:1999;266-270.
118. Vatassery G.T., Bauer T., Dysken M. High doses of Vitamin E in the treatment of disorders of the central nervous system in the aged. Am. J. Clin. Nutr. 70:1999;793-801.
119. Veldman B.A., Wijn A.M., Knoers N., Praamstra P., Horstink M.W. Genetic and environmental risk factors in Parkinson's disease. Clin. Neurol. Neurosurg. 100:1998;15-26.
120. Walton M., Henderson C., Mason-Parker S., Lawlor P., Abraham W.C., Bilkey D.et al. Immediate early gene transcription and synaptic modulation. J. Neurosci. Res. 58:1999;96-106.
121. Weindruch R., Sohal R.S. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N. Engl. J. Med. 337:1997;986-994.
122. Wiese S., Digby M.R., Gunnersen J.M., Gotz R., Pei G., Holtmann B.et al. The antiapoptotic protein ITA is essential for NGF-mediated survival of embryonic chick neurons. Nat. Neurosci. 2:1999;978-983.
123. Yandava B.D., Billinghurst L.L., Snyder E.Y. "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7029-7034.
124. Yu Z.F., Mattson M.P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57:1999;830-839.
125. Yu Z.F., Luo H., Fu W., Mattson M.P. The endoplasmic reticulum stress-responsive protein GRP-78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 155:1999;302-314.
126. Zhu H., Guo Q., Mattson N.P. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res. 842:1999;224-229.